BBNX Beta Bionics, Inc.
Healthcare$11.72-0.85%ClosedMarket Cap: $522.3M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$21.00
Target (Median)
$22.00
Target Range
$14.00 - $25.00
Upside from current price: 79.2%
Rating Distribution
1 Strong Buy7 Buy3 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-18 | B of A Securities | maintain | Neutral | Neutral |
| 2026-04-22 | Leerink Partners | maintain | Outperform | Outperform |
| 2026-04-22 | Stifel | maintain | Buy | Buy |
| 2026-04-15 | Truist Securities | maintain | Buy | Buy |
| 2026-04-09 | Goldman Sachs | maintain | Buy | Buy |
| 2026-02-18 | Stifel | maintain | Buy | Buy |
| 2026-02-18 | Baird | maintain | Neutral | Neutral |
| 2026-02-02 | Truist Securities | maintain | Buy | Buy |
| 2026-01-09 | Lake Street | maintain | Buy | Buy |
| 2026-01-05 | B of A Securities | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.11 | $180.4M | 6 |
| Sun Dec 31 | $-1.51 | $251.7M | 8 |
| Mon Dec 31 | $-1.15 | $343.1M | 6 |
| Tue Dec 31 | $0.06 | $466.1M | 6 |